News and Deals
Linklaters advises QIAGEN on recommended voluntary all-cash public takeover offer by EQT
Press Contact
Jörg Overbeck
PR/Communications Lead
+49 1726907510
joerg.overbeck@linklaters.com
News and Deals
Press Contact
Jörg Overbeck
PR/Communications Lead
+49 1726907510
joerg.overbeck@linklaters.com
Linklaters advises QIAGEN N.V. on the agreement with EQT Private Equity on an all-cash public takeover offer for all outstanding QIAGEN shares, at an offer price of €46.50 per share. The bidder is a holding company indirectly controlled by EQT XI fund with further indirect participations held by co-investors Luxinva S.A., a wholly-owned subsidiary of the Abu Dhabi Investment Authority, and CPP Investment Board Europe Inc., a wholly-owned subsidiary of Canada Pension Plan Investment Board.
The transaction values QIAGEN at approx. €10.8bn in enterprise value – approx. $12.1bn at current exchange rates, including approximately $1.1bn of net debt.
QIAGEN N.V., a Netherlands-based holding company, is a global leader in Sample to Insight solutions that enable customers to extract and analyse molecular information from biological samples containing the building blocks of life. QIAGEN serves more than 500,000 customers worldwide in the Life Sciences and clinical healthcare sectors. It employs about 5,400 people across more than 35 locations.
An international cross-practice Linklaters team led by Corporate/M&A partner Staffan Illert and Daniela Seeliger (Antitrust & Foreign Investment) advised QIAGEN on this complex landmark transaction. The team also included partner David dos Santos Goncalves (Antitrust & Foreign Investment), Alexander Schlee (Capital Markets), counsels Ben Bauer (Antitrust & Foreign Investment, New York), Ulli Janssen (Corporate/M&A), Tobias Rump (Antitrust & Foreign Investment), Will Creswell (Capital Markets), Urs Lewens (Banking), managing associates Kevin Eisenschmidt (Corporate/M&A), Catrin Retzmann (Capital Markets) and associates Kathy Choi (London) and Theresa Noßke (both Antitrust & Foreign Investment).
Linklaters is a leading advisor on complex cross-border M&A transactions. In the latest M&A rankings of LSEG, the firm was listed No.1 for completed deals with German involvement, having advised on 31 deals with a total value of about $38bn, reflecting a market share of 28% (1/1/26-30/09/26).